production cost and added product value and increase the Company service’s abilities and support the water management business expansion. On 12 October 2018, the Board of Directors of WIIK passed resolution
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
received from current investment. 2. Cost of sale , Profit margin In Q2/2017 the company had cost of sale Baht 82.97 million compare with the same period of previous year amount to Baht 68.01 million
for the openness of the free trade policy Economic expansion in the developing countries and the continued growth of low-cost airlines, especially in Asia. For the total multi-products fuel
effectively. Consequently, we recorded Bt5,251mn in revenue, growing 26% YoY. Soften EBITDA from cost pressure AIS EBITDA in FY22 was Bt89,731mn, dropped -1.8%YoY mostly from a surging electricity price and
the Company had reduced the registered capital by decreasing the registered capital of the other joint venture. As a result, the joint venture agreement is terminated and the company is a major
1: Overall Financial Performance Unit: million baht Jan-Mar 2019 % Jan-Mar 2020 % Change % YoY Revenue 132.54 100.0% 179.21 100.0% 46.67 35.2% Cost (73.41) (55.4%) (93.71) (52.3%) (20.30) 27.7% Gross